Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Immune cell 'survival' gene key to better myeloma treatments

04.02.2013
Scientists have identified the gene essential for survival of antibody-producing cells, a finding that could lead to better treatments for diseases where these cells are out of control, such as myeloma and chronic immune disorders.

The discovery that a gene called Mcl-1 is critical for keeping this vital immune cell population alive was made by researchers at Melbourne's Walter and Eliza Hall Institute. Associate Professor David Tarlinton, Dr Victor Peperzak and Dr Ingela Vikstrom from the institute's Immunology division led the research, which was published today in Nature Immunology.

Antibody-producing cells, also known as plasma cells, live in the bone marrow and make antibodies that provide a person with long-term protection from viruses and bacteria, Associate Professor Tarlinton said. "Plasma cells are produced after vaccination or infection and are responsible for the immune 'memory' that can persist in humans for 70 or 80 years. In this study, we found that plasma cells critically rely on Mcl-1 for their continued survival and, without it, they die within two days," he said.

Dr Peperzak said the team was surprised to find that plasma cells used this as a 'failsafe' mechanism in controlling their survival. "One of the interesting things we found is that because plasma cells rapidly destroy Mcl-1 proteins within the cell yet depend on it for their survival, they need continuous external signals to tell them to produce more Mcl-1 protein," Dr Peperzak said. "This keeps the plasma cells under tight control, with Mcl-1 acting like a timer that constantly counts down and, if not reset, instructs the cell to die."

Plasma cells are vital to the immune response, but can be dangerous if not properly controlled, Associate Professor Tarlinton said. "As with any immune cell, plasma cells are really quite dangerous in many respects and need to be tightly controlled," he said. "When they are out of control they continue to make antibodies that can be very damaging if there are too many. This happens in conditions such as myeloma – a cancer of plasma cells – and various forms of autoimmunity, such as systemic lupus erythamatosus or rheumatoid arthritis, where there are excessive levels of antibodies."

Myeloma is a blood cancer that affects more than 1200 Australians each year, and is more common in people over 60. It is caused by the uncontrolled production of abnormal plasma cells in the bone marrow and the build up of damaging antibodies in the blood. Rheumatoid arthritis and lupus are autoimmune diseases in which the antibodies produced by plasma cells attack and destroy the body's own tissues.

Associate Professor Tarlinton said that his hope was that the discovery could be used to develop new treatments for these conditions. "Myeloma in particular has a very poor prognosis, and is generally considered incurable," Associate Professor Tarlinton said. "Now that we know Mcl-1 is the one essential gene needed to keep plasma cells alive, we have begun 'working backwards' to identify all the critical molecules and signals needed to switch on Mcl-1 and keep the cells alive. Our hope is that we will identify some point in the internal cell signalling pathway, or a critical external molecule, that could be blocked to stop Mcl-1 being produced by the cell. This would be an important new platform for diseases that currently have no specific or effective treatment, such as myeloma, or offer new treatment options for people who don't respond well to existing treatments for diseases such as lupus or rheumatoid arthritis."

This research was supported by the National Health and Medical Research Council of Australia, Multiple Myeloma Research Foundation, European Molecular Biology Organization and the Victorian Government.

Liz Williams | EurekAlert!
Further information:
http://www.wehi.edu.au

More articles from Life Sciences:

nachricht Killer sea snail a target for new drugs
07.07.2015 | University of Queensland

nachricht First images of dolphin brain circuitry hint at how they sense sound
07.07.2015 | Emory Health Sciences

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Molekulare Container für die Gewinnung Seltener Erden: Neues Forschungsprojekt „SE-FLECX“ gestartet

Seltene Erden sind begehrt, weil sie für die Herstellung vieler Hightech-Produkte benötigt werden. Allerdings ist ihre Gewinnung aus Erzen aufwendig und häufig umweltbelastend.

Experten aus Forschung und Industrie testen derzeit unter Koordination des Helmholtz-Instituts Freiberg für Ressourcentechnologie, ob so genannte Calixarene...

Im Focus: Surfing a wake of light

Researchers observe and control light wakes for the first time

When a duck paddles across a pond or a supersonic plane flies through the sky, it leaves a wake in its path. Wakes occur whenever something is traveling...

Im Focus: Auf den Quantenpunkt gebracht: ultrahochauflösendes 3D-Mikroskopieverfahren für elektrische Felder

Mit einem einzelnen Molekül als Sensor ist es Jülicher Wissenschaftlern gelungen, elektrische Potenzialfelder in bisher unerreichter Präzision abzubilden. Die ultrahochaufgelösten Aufnahmen geben Aufschluss über die Verteilung von Ladungen in der Elektronenhülle einzelner Moleküle und sogar Atome. Die Methode arbeitet berührungsfrei und in 3D.

Erste Ergebnisse der als Raster-Quantenpunkt-Mikroskopie bezeichneten Technik sind in der aktuellen Ausgabe der Fachzeitschrift Physical Review Letters...

Im Focus: Magnettests an Wendelstein 7-X erfolgreich abgeschlossen

Wichtiger Schritt der Betriebsvorbereitung / erstes Plasma in der Fusionsanlage rückt näher

Mit dem erfolgreich abgeschlossenen Test aller siebzig Magnetspulen ist jetzt die Funktion der technologischen Schlüsselkomponente für das Fusionsexperiment...

Im Focus: Neues Verfahren ermöglicht 3D-Auslesung von magnetischen Mustern

Eine internationale Kooperation hat es geschafft, mit Synchrotronlicht komplexe Magnetisierungsmuster in gewickelten magnetischen Schichten dreidimensional auszulesen. Dieses Verfahren könnte interessant sein, um hochempfindliche Sensoren für Magnetfelder zu entwickeln, beispielsweise für die medizinische Diagnostik. Die Ergebnisse sind in Nature Communications publiziert.

Feine Strukturen im Inneren von Materialien und biologischen Proben lassen sich heute mit Röntgentomographie gut ermitteln: Dabei werden Schicht für Schicht...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

Global Communication Association Konferenz: Drei Tage im Zeichen des digitalen Wandels

07.07.2015 | Veranstaltungen

IMTC 2015: Internationale Fachtagung im Kompetenzfeld Leichtbau

06.07.2015 | Veranstaltungen

Rheumatologen tagen in Bremen: Fortschritte in der Rheuma-Therapie und neue Impfempfehlungen

06.07.2015 | Veranstaltungen

 
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

Ein schwarzes Loch unter der Gravitationslinse

07.07.2015 | Physik Astronomie

Nanodraht-Netz sagt Muskelkater den Kampf an

07.07.2015 | Medizin Gesundheit

Studie über Bio-Hacking: Öffnen wir unsere Haustüren bald mit Chip-Implantaten?

07.07.2015 | Medizin Gesundheit